Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07843030 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect and Mechanism of Jiajian Guishen Optimized Formula on Premature Ovarian Insufficiency: Insights Into m6A Modification and Oxidative Stress

Study acronym: JJGS ; POI
StatusNot Yet Recruiting
PhaseEarly Phase 1
SponsorShi Yun
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Shi Yun
4 trials monitored
See all monitored trials
The goal of this clinical study is to evaluate the effectiveness of JiaJian GuiShen Optimized Formula (JJGS) and explore its mechanisms involving m6A modification and oxidative stress in women with premature ovarian insufficiency (POI). The main question it aims to answer is: Does JJGS improve ovarian function in women with POI after three menstrual cycles of treatment? Twenty-five women with POI will receive JJGS, and 20 healthy women will serve as controls. Changes in FSH, E2, LH, AMH, oxidative stress markers, plasma FTO levels, whole-blood RNA m6A levels, and symptom scores will be analyzed before and after treatment.
Trial Details
NCT Number NCT07843030
Lead Sponsor Shi Yun
Conditions
(from sponsor)		 Premature Ovarian Insufficiency
Related terms Primary Ovarian Insufficiency
Enrollment 45 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov